BT
0
Active Trials
0
Total Trials
0
Organizations
0
Events
Bhutan
Medical Only (Private)
Reimbursed Care Access
Bhutan’s narcotics and psychotropic controls are implemented through domestic law that adopts the UN schedules; most classical psychedelics (psilocybin, MDMA, DMT, mescaline, etc.) are classified with no authorized medical use except within tightly regulated medical/scientific channels. Ketamine is used in medical settings (anesthesia) under controlled-drug rules, but specialized psychiatric products such as esketamine (Spravato) are not registered or reimbursed in Bhutan and have no routine psychiatric reimbursement pathway.
No clinical trials found for this country yet.